Footbeat Receives Funding To Improve Lower Body Circulation For Athletic Recovery

Footbeat is wearable technology that improves health and athletic performance by increasing circulation through cyclic pressure that is applied to the arch of the foot.

AVEX LCC, a Colorado-based medical device company, announced Tuesday that it secured $7.6 million in Series A financing that will fuel the launch of Footbeat this year.

“We believe that an investment of this magnetite validates both the clinical and commercial potential of Footbeat,” AVEX CEO Matt Mayer said in a statement. “We’re bringing a device to market that will transform lives through improved health and athletic recovery. The capital raised in this round will build up production capacity, expand the operations team, and provide the sales and marketing resources to make Footbeat available to patients and physicians.”

In the arch of Footbeat, there is a foot pump, or plantar venous plexus. When pressure is put on the pump by a smart engine in the insole of the Footbeat Moc shoe, blood is forced into the veins of the leg and then onto they heart. This pump helps play a role in the venous system, is a transportation network that supplies oxygen and nutrients to your body while also removing metabolic waste.

With Footbeat applying pressure at regular intervals into the arch of the foot, it is able to create physical benefits. These benefits mimic the benefits people get naturally from increased circulation due to physical activity including increased removal of metabolic waste and increased delivery of important nutrients that help accelerate healing and recovery.

The micro-mechanical device can be activated using mobile technology in the form of a remote control.